Chronoimmunology is a field of study that explores the intricate relationship between the immune system and circadian rhythms, which are daily fluctuations in biological processes tied to the 24-hour day-night cycle. The immune system exhibits a rhythmic pattern of activity, impacting various immune processes such as the production of cytokines, immune cell activity, and susceptibility to infections. Circadian rhythms influence the functioning of immune cells, including T cells, B cells, and macrophages, as well as the release of immune-modulating substances. Disruptions to circadian rhythms, such as those caused by shift work, irregular sleep patterns, or jet lag, can adversely affect immune function. Research in chronoimmunology has implications for understanding how the timing of interventions, such as vaccinations or drug administration, can optimize immune responses. The circadian regulation of immune processes is intricately connected to the overall health of an individual and may contribute to variations in disease susceptibility and severity at different times of the day. A comprehensive understanding of chronoimmunology has the potential to inform personalized medicine approaches, improve vaccine efficacy, and enhance strategies for managing immune-related disorders.
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Overcoming biophysical characterization challenges of small antigens in dilute vaccine formulations
Eric Kemp, Merck & Co., United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : A combined LC-MS and immunoassay approach to characterize preservative-induced destabilization of human papillomavirus virus-like particles adsorbed to an aluminum-salt adjuvant
Ria T Caringal, University of Kansas, United States